scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0140-6736(78)92882-9 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673678928829?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0140673678928829?httpAccept=text/xml | ||
P698 | PubMed publication ID | 79916 |
P2093 | author name string | J. Wu | |
J. Hambley | |||
R. S. Elkeles | |||
P2860 | cites work | Diabetologia | Q5270140 |
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study | Q40070458 | ||
Serum high density lipoprotein in diabetic patients | Q40106306 | ||
Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus | Q44199581 | ||
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. | Q53751216 | ||
Hemoglobin components in patients with diabetes mellitus | Q71748906 | ||
Correlation of glucose regulation and hemoglobin AIc in diabetes mellitus | Q34065358 | ||
The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study | Q39433797 | ||
Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes | Q39442248 | ||
Haemoglobin A1: An indicator of the metabolic control of diabetic patients | Q39455164 | ||
Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus | Q39493777 | ||
P433 | issue | 8089 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
glycobiology | Q899224 | ||
HDL cholesterol | Q67322514 | ||
P304 | page(s) | 547-549 | |
P577 | publication date | 1978-09-01 | |
1978-09-09 | |||
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Haemoglobin A1, blood glucose, and high-density lipoprotein cholesterol in insulin-requiring diabetics | |
P478 | volume | 2 |
Q72804309 | Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: Cholesterol acyltransferase activity in diabetes mellitus |
Q39590604 | Beta Thromboglobulin and Glycosylated Haemoglobin in Diabetes Mellitus |
Q47254796 | Changes in High Density Lipoprotein Cholesterol after Initiation of Insulin Therapy in Non-Insulin Dependent Diabetes Mellitus: Relationship to Changes in Body Weight |
Q37934887 | Dyslipoproteinemia and diabetes. |
Q51648382 | Glycosylated hemoglobin (Hb AI) as an indicator of therapy effects in different clinical types of diabetes. |
Q71422603 | Glycosylated hemoglobin (HbAtc) and plasma lipoproteins in juvenile onset diabetes mellitus |
Q71399683 | Haemoglobin A1c, home urine sugar testing and serum cholesterol and HDL-cholesterol in diabetic children |
Q37934820 | Hyperlipidemia in diabetes mellitus. |
Q51655878 | Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics. |
Q40280363 | Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children |
Q39668159 | Nonenzymatically glycosylated proteins. |
Q40328402 | Regulation of high density lipoprotein levels |
Q72651132 | Relationships between metabolic and hemostatic variables in uncomplicated diabetes |
Q51651383 | Serum lipid and lipoprotein levels and metabolic control in insulin-treated diabetics. |
Q51658569 | Serum lipoproteins in diabetes: relation of alpha-lipoprotein level to therapy. |
Q40259675 | The clinical utility of glycosylated hemoglobin |
Q92262038 | The effects of GSK2981710, a medium-chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo-controlled study |
Q41614067 | The relationship between blood glycosylated haemoglobin and home capillary blood glucose levels in diabetics |
Q36682315 | Treatment of diabetes: the effect on serum lipids and lipoproteins |
Search more.